IL‐33 induces skin inflammation with mast cell and neutrophil activation
- 15 June 2011
- journal article
- research article
- Published by Wiley in European Journal of Immunology
- Vol. 41 (8) , 2229-2237
Abstract
Psoriasis is a common chronic autoimmune condition of the skin characterized by hyperplasia of epidermal keratinocytes associated with pro‐inflammatory cytokines. IL‐33 is a new member of the IL‐1 superfamily that signals through the ST2 receptor and was originally defined as an inducer of T helper 2 (Th2) cytokines. Recently, broader immune activatory potential has been defined for IL‐33 particularly via mast cell activation and neutrophil migration. Here, we show that ST2−/− mice exhibit reduced cutaneous inflammatory responses compared with WT mice in a phorbol ester‐induced model of skin inflammation. Furthermore, injections of IL‐33 into the ears of mice induce an inflammatory skin lesion. This inflammatory response was partially dependent on mast cells as mast cell‐deficient mice (KitW‐sh/W‐sh) showed delayed responses to IL‐33. IL‐33 also recruited neutrophils to the ear, an effect mediated in part by increased production of the chemokine KC (CXCL1). Finally, we show that IL‐33 expression is up‐regulated in the epidermis of clinical psoriatic lesions, compared with healthy skin. These results therefore demonstrate that IL‐33 may play a role in psoriasis‐like plaque inflammation. IL‐33 targeting may provide a new treatment strategy for psoriasis.Keywords
This publication has 40 references indexed in Scilit:
- IL-33 augments substance P–induced VEGF secretion from human mast cells and is increased in psoriatic skinProceedings of the National Academy of Sciences, 2010
- A crucial role for TNF‐α in mediating neutrophil influx induced by endogenously generated or exogenous chemokines, KC/CXCL1 and LIX/CXCL5British Journal of Pharmacology, 2009
- Interleukin-33 Is Biologically Active Independently of Caspase-1 CleavageJournal of Biological Chemistry, 2009
- RETRACTED: The cytokine interleukin-33 mediates anaphylactic shockProceedings of the National Academy of Sciences, 2009
- The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1Proceedings of the National Academy of Sciences, 2009
- The IL-1-Like Cytokine IL-33 Is Constitutively Expressed in the Nucleus of Endothelial Cells and Epithelial Cells In Vivo: A Novel ‘Alarmin’?PLOS ONE, 2008
- Nuclear Interleukin-33 Is Generally Expressed in Resting Endothelium but Rapidly Lost upon Angiogenic or Proinflammatory ActivationThe American Journal of Pathology, 2008
- Opposing activities of two novel members of the IL-1 ligand family regulate skin inflammationJournal of Experimental Medicine, 2007
- IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factorin vivoProceedings of the National Academy of Sciences, 2007
- Mast Cell-Deficient W-sash c-kit Mutant KitW-sh/W-sh Mice as a Model for Investigating Mast Cell Biology in VivoThe American Journal of Pathology, 2005